PRF Technologies Ltd. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · Israel
Last price 0.7502 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.63M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Details
| Name | PRF Technologies Ltd. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 7 |
| Founded | 2007 |
| Ipo Date | 2020-09-01 |
| Ceo | Efraim Cohen-Arazi |
| Country | Israel |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 8.00 |
| Isin | IL0011651580 |
| Cusip | M77798201 |
| Cik | 1801834 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Efraim Cohen-Arazi | Interim Chief Executive Officer and Director |
| Dr. Ehud Geller Ph.D. | Executive Chairman |
| Eyal Broder | Chief Financial Officer |
| Dr. Sigal Aviel eMBA, Ph.D. | Chief Operating Officer |
| Rita Keynan M.Sc. | Vice President of Pharmaceutical Operations |
Contact
| Address | 65 Yigal Alon St., Tel Aviv, 6744316, Israel |
| Phone | 972 3 7177050 |
| Website | https://www.painreform.com |